Immuno-Biological Laboratories Co., Ltd.
Immuno-Biological Laboratories Co., Ltd. (JPX: 4570) is trading at ¥1,199.00, about ₹732 at today's JPY/INR rate, as of 30 Sep 2026, 2:30 AM ET, up 3.81% today. Indian residents can buy Immuno-Biological Laboratories from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
¥1,145.00
Today's high
¥1,210.00
52 week low
¥464.00
52 week high
¥3,820.00
4570 opened at ¥1,154.00, closed previously at ¥1,155.00, and has traded between ¥464.00 and ¥3,820.00 over the past 52 weeks.
About
Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to the research, development, production, and distribution of immunological reagents. The company's diverse offerings include ELISA assay kits designed for the precise quantitative measurement of targeted substances, alongside comprehensive research support services focusing on areas such as Alzheimer's disease, metabolic syndrome, and cancer. IBL also caters to specific client needs through customized services for antibody production and the development of bespoke ELISA systems. A prominent service is LipoSEARCH, which provides tailored lipoprotein profiling and analysis utilizing gel-filtration high-performance liquid chromatography. This advanced method allows for the in-depth examination of even minute plasma or serum samples from both humans and small animals, supporting a broad spectrum of research, including lipid metabolism, the creation of pharmaceuticals for lifestyle-related diseases, functional food development, and clinical investigations. For animal health, IBL offers LipoTEST, a diagnostic and health screening tool for veterinary clinics, complemented by personalized biomarker testing services for lifestyle-related conditions. Furthermore, the company operates an innovative protein production division that leverages transgenic silkworms. This technology is instrumental in manufacturing antibodies for research and diagnostic applications, human collagen for cosmetic use, proteins for drug development, and other specialized proteins. Established in 1982, Immuno-Biological Laboratories Co., Ltd. is headquartered in Fujioka, Japan.
Key statistics
Avg. volume
127.75K
Market cap
¥11.17B
P/E Ratio
30.32
Price-to-sales ratio
10.34
Enterprise value
¥11.69B
Free cash flow yield
2.14%
Debt-to-equity ratio
0.09
Return on equity
17.85%
ROIC
13.81%
Beta
-0.02
Dividend yield
0.50%
Last dividend
¥6.00
Financial overview
Revenue
¥1.00B
Earnings per share
¥35.33
Free cash flow
¥267.68M
Net profit margin
34.12%
Gross margin
72.02%
EBITDA
¥299.82M
Revenue growth
3.66%
Similar securities
This is not an investment recommendation
How to buy Immuno-Biological Laboratories from India
Indian residents can buy Immuno-Biological Laboratories shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.
Search for Immuno-Biological Laboratories and place an order
Find Immuno-Biological Laboratories by name or by its ticker, 4570, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Immuno-Biological Laboratories trades 5:30 am – 12:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Immuno-Biological Laboratories position in JPY and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Immuno-Biological Laboratories from India
Trading and taxes when buying Immuno-Biological Laboratories from India
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm JST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Immuno-Biological Laboratories’ current yield is 0.50%.Dividend tax explained
- Estate or inheritance tax
- May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Immuno-Biological Laboratories stock?
Yes. Immuno-Biological Laboratories (4570) has been listed on the Tokyo Stock Exchange since 2007, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Immuno-Biological Laboratories share cost in rupees?
One Immuno-Biological Laboratories share is ¥1,199.00 — about ₹732 at a JPY/INR rate of 0.6103 on 29 Sep 2026. Both the Immuno-Biological Laboratories price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Immuno-Biological Laboratories from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Immuno-Biological Laboratories?
The Tokyo Stock Exchange typically trades in units of 100 shares.
How are gains on Immuno-Biological Laboratories shares taxed in India?
Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Immuno-Biological Laboratories price. Paasa issues a capital-gains statement for your return.
Does Immuno-Biological Laboratories pay a dividend, and how is it taxed in India?
Yes. Immuno-Biological Laboratories pays a dividend and the current yield is 0.50%; the last declared dividend was ¥6.00 per share, about ₹3.66. Dividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Immuno-Biological Laboratories from India?
The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Immuno-Biological Laboratories shares held from India?
Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.
Do I have to declare Immuno-Biological Laboratories shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Immuno-Biological Laboratories holding, its cost and its closing value.
How do I sell Immuno-Biological Laboratories and bring the money back to India?
You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.